Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs

Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs

Bibliographic Details
Main Authors:	Cy Stein, Daniela Castanotto, Amrita Krishnan, Liana Nikolaenko
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	Molecular Therapy: Nucleic Acids
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253117300653

Similar Items

Maximizing the Value of Drug Stockpiles for Pandemic Influenza
by: Alain Li Wan Po, et al.
Published: (2009-10-01)

Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
by: Ran D. Balicer, et al.
Published: (2005-08-01)

Defibrotide in the treatment of hepatic veno-occlusive disease
by: Fulgenzi A, et al.
Published: (2016-10-01)

Pharmacokinetic profile of defibrotide in patients with renal impairment
by: Tocchetti P, et al.
Published: (2016-08-01)

Antiviral resistance during pandemic influenza: implications for stockpiling and drug use
by: Bowman Christopher S, et al.
Published: (2009-01-01)

Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations
by: Di Maria Jiang, et al.
Published: (2019-04-01)

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs
by: Robert N. Schuck, et al.
Published: (2019-05-01)

Food and Drug Administration approvals in phase 3 Cancer clinical trials
by: Joseph Abi Jaoude, et al.
Published: (2021-06-01)

Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
by: Ashley L. Eadie, et al.
Published: (2021-05-01)

In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
by: Jingjing Yu, et al.
Published: (2020-07-01)

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
by: Szymon Jarosławski, et al.
Published: (2018-01-01)

Fingolimod: The first oral drug approved by food and drug administration; A breakthrough in treatment of multiple sclerosis
by: Manish Singh, et al.
Published: (2011-01-01)

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
by: Fei Liang, et al.
Published: (2020-08-01)

U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations
by: Nadia Zuabi, et al.
Published: (2016-11-01)

Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review
by: Bonet Olivencia, Samuel, et al.
Published: (2021-03-01)

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
by: Joshua D. Wallach, et al.
Published: (2019-06-01)

Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis
by: Nicoletta Orlando, et al.
Published: (2020-12-01)

Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
by: Julia Martinez-Sanchez, et al.
Published: (2019-10-01)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
by: Maria Gagliardi, et al.
Published: (2021-04-01)

Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations
by: Yassine Kamal Lyauk, et al.
Published: (2019-09-01)

Tetrahedral framework nucleic acids as an advanced drug delivery system for oligonucleotide drugs
by: Yuhao Liu, et al.
Published: (2020-10-01)

Approval of raxibacumab for the treatment of inhalation anthrax under the US Food and Drug Administration Animal rule
by: Chia-Wei eTsai, et al.
Published: (2015-12-01)

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information
by: Felix W. Frueh, et al.
Published: (2013-06-01)

Association between Health Practice and Food Stockpiling for Disaster
by: Moeka Harada, et al.
Published: (2021-04-01)

Stockpiling Ventilators for Influenza Pandemics
by: Hsin-Chan Huang, et al.
Published: (2017-06-01)

Stockpiling Ventilators for Influenza Pandemics
by: Martin I. Meltzer, et al.
Published: (2017-06-01)

A new philosophy for stockpiling.
by: Gordon, Donald B.
Published: (2012)

Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
by: James M McCaw, et al.
Published: (2008-01-01)

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
by: Karishma Dhuri, et al.
Published: (2020-06-01)

Drug lag for cardiovascular drug approvals in India compared with the US and EU approvals
by: Bhaven C. Kataria, et al.
Published: (2013-01-01)

Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation
by: Bhausaheb Bagal, et al.
Published: (2018-03-01)

Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
by: Erik De Clercq
Published: (2019-02-01)

Stockpiling Security and Reducing Surplus Weapons.
by: Greene, Owen J.
Published: (2010)

Stockpiling Supplies for the Next Influenza Pandemic
by: Lewis J. Radonovich, et al.
Published: (2009-06-01)

Simulation Applied to the Storage Capacity and Stockpiles
by: Andrea Alejandra Giubergia, et al.
Published: (2016-05-01)

Direct stockpile scheduling: Mathematical formulation
by: Felipe Ribeiro Souza, et al.
Published: (2018-01-01)

Wind erosion modelling of stockpiles and embankments
by: Chane Kon, Laurent
Published: (2004)

Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity
by: McKiernan Erin C, et al.
Published: (2011-08-01)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
by: Julien Dugal-Tessier, et al.
Published: (2021-02-01)

Medicinal Chemistry of Oligonucleotide Drugs - Milestones of the Past and Visions for the Future
by: Ashkinadze, A., et al.
Published: (2022)